Dana-Farber PLGA Program Director

Pratiti (Mimi)Bandopadhayay, MBBS, PhD

Mimi Bandopadhayay, MBBS, PhD is the Director of the PLGA Program at Dana-Farber.  She is a pediatric neuro-oncologist and scientist within the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, an Assistant Professor of Pediatrics at HMS, and an associate member of the Broad Institute of MIT.  Mimi applies integrative genomic approaches to identify targetable drivers of pediatric brain tumors and characterize resistance mechanisms.  In addition to her efforts in the lab, Mimi is a member of the clinical pediatric neuro-oncology team at Dana-Farber/Boston Children’s, contributing to the care of children with brain tumors.

Dana-Farber PGLA Executive Committee

The five member Dana-Farber PLGA Executive Committee oversees with the Director the overall direction of the scientific program.

  • Scott A. Armstrong, MD, PhD, David G. Nathan Professor of Pediatrics, Pediatrics-Boston Children’s Hospital, Harvard Medical School; Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute
  • Daphne Haas-Kogan, MD, Radiation Oncology Professor at Harvard Medical School, Head of the Department of Radiation Oncology at the Brigham and Women’s Hospital, Children’s Hospital, and Dana-Farber Cancer Institute
  • Katherine E. Warren, MD, Member of the Faculty of Pediatrics, Pediatrics-Boston Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School; Director of Pediatric Neuro-Oncology, Dana-Farber Cancer Institute
  • Michael J. Eck, MD, PhD, Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Department of Cancer Biology, Dana-Farber Cancer Institute
  • Rameen Beroukhim, MD, PhD, Associate Professor of Medicine, Medicine-Brigham and Women’s Hospital, Harvard Medical School; Department of Cancer Biology, Dana-Farber Cancer Institute